Wang Doctor Chief Physician

The First Affiliated Hospital, Sun Yat-sen University · Gynecology · Chief Physician

Dr. Wei Wang is a gynecological oncologist at The First Affiliated Hospital, Sun Yat-sen University, with a PhD from the same institution. A member of the Guangdong Medical Association and Chinese Anti-Cancer Association, his research focuses on cervical cancer metastasis and treatment. He has published extensively in high-impact journals (e.g., Oncogene, Cell Death Dis) as first or co-corresponding author, exploring molecular mechanisms like fatty acid metabolism and immune escape.

Proficient in standardized and minimally invasive diagnosis and treatment of benign and malignant gynecological tumors and endometriosis. Specializes in laparoscopic and abdominal surgeries for benign and malignant gynecological tumors and deep infiltrating endometriosis, particularly radical hysterectomy for cervical cancer, staging surgery for endometrial cancer, cytoreductive surgery for ovarian cancer, and laparoscopic radical resection of deep infiltrating pelvic endometriosis (including ur

Wang Doctor
Doctor Photo
Basic Information

About Dr. Wang Doctor

Hospital
The First Affiliated Hospital, Sun Yat-sen University
Title
Chief Physician
Department
Gynecology
Years of Practice
28 years (1998 — present)
**Education and Professional Experience:** 2012–2015 Sun Yat-sen University, Doctoral Candidate 2015–Present The First Affiliated Hospital, Sun Yat-sen University **Professional Affiliations:** Member, Gynecological Oncology Branch, Guangdong Medical Association Member, Endoscopic and Robotic Surgery Branch, Chinese Anti-Cancer Association **Publications:** (1) Liao Y, Huang J, Liu P, Zhang C, Liu J, Xia M, Shang C, Ooi S, Chen Y, Qin S, Du Q, Liu T, Xu M, Zou Q, Zhou Y, Huang H, Pan Y, Wang W (Co-Corresponding Author), Yao S. Downregulation of LNMAS orchestrates partial EMT and immune escape from macrophage phagocytosis to promote lymph node metastasis of cervical cancer. ONCOGENE 2022, 41(13): 1931-1943. (IF: 9.867; Q1). (2) Zhang C, Liu P, Huang J, Liao Y, Pan C, Liu J, Du Q, Liu T, Shang C, Ooi S, Chen R, Xia M, Jiang H, Xu M, Zou Q, Zhou Y, Huang H, Pan Y, Yuan L, Wang W (Co-Corresponding Author), Yao S. Circular RNA hsa_circ_0043280 inhibits cervical cancer tumor growth and metastasis via miR-203a-3p/PAQR3 axis. CELL DEATH DIS 2021, 12(10): 888 (IF: 8.469; Q1). (3) Zhang C, Liao Y, Liu P, Du Q, Liang Y, Ooi S, Qin S, He S, Yao S, Wang W (Corresponding Author). FABP5 promotes lymph node metastasis in cervical cancer by reprogramming fatty acid metabolism. THERANOSTICS 2020, 10(15): 6561-6580 (IF: 11.566; Q1). (4) Liu P, Zhang C, Liao Y, Liu J, Huang J, Xia M, Chen M, Tan H, He W, Xu M, Liu T, Ooi S, Du Q, Qin S, Zhu Y, Zou Q, Wang W (Co-Corresponding Author), Yao S. High expression of PTPRM predicts poor prognosis and promotes tumor growth and lymph node metastasis in cervical cancer. CELL DEATH DIS 2020, 11(8): 687 (IF: 8.469; Q1). (5) He S, Wang W (Co-First Author), Wan Z, Shen H, Zhao Y, You Z, Liu J, Zhu L. FAM83B inhibits ovarian cancer cisplatin resistance through inhibiting Wnt pathway. ONCOGENESIS 2021, 10(1): 6 (IF: 7.485; Q1). (6) Wang W (First Author), Jia H, Huang J, Liang Y, Tan H, Geng H, Guo L, Yao S. Identification of biomarkers for lymph node metastasis in early-stage cervical cancer by tissue-based proteomics. BRIT J CANCER 2014, 110(7): 1748-1758 (IF: 7.64; Q1). (7) Wang W (First Author), Chu HJ, Shang CL, Gong X, Liu TY, Zhao YH, Huang JM, Yao SZ. Long-Term Oncological Outcomes After Laparoscopic Versus Abdominal Radical Hysterectomy in Stage IA2 to IIA2 Cervical Cancer: A Matched Cohort Study. INT J GYNECOL CANCER 2016, 26(7): 1264-1273. (8) Wang W (First Author), Shang C, Du Q, Wu D, Liang Y, Liu T, Huang J, Yao S. Class I versus Class III radical hysterectomy in stage IB1 (tumor ≤ 2 cm) cervical cancer: a matched cohort study. J CANCER 2017, 8(5): 825-831. (9) Shang C, Wang W, Liao Y, Chen Y, Liu T, Du Q, Huang J, Liang Y, Liu J, Zhao Y, Guo L, Hu Z, Yao S. LNMICC Promotes Nodal Metastasis of Cervical Cancer by Reprogramming Fatty Acid Metabolism. CANCER RES 2018, 78(4): 877-890. (10) Wang Wei, Yao Shuzhong. Diagnosis and treatment of cervical insufficiency during pregnancy. Journal of Practical Obstetrics and Gynecology 2018, 34(02): 90-93. (11) Wang Wei, Yao Shuzhong. Indications and controversies of lymphadenectomy for cervical cancer. Chinese Journal of Practical Gynecology and Obstetrics 2017, 33(12): 1237-1241. (12) Wang Wei, Yao Shuzhong. Endoscopic surgery for uterine infertility. Journal of Practical Obstetrics and Gynecology 2015, 31(03): 161-163. (13) Wang Wei, Shang Chunliang, Huang Jiaming, Chen Shuqin, Shen Huimin, Yao Shuzhong. A matched cohort study on the feasibility and oncological outcomes of laparoscopic versus abdominal radical hysterectomy for stage Ia2 to IIa2 cervical cancer. Chinese Journal of Obstetrics and Gynecology 2015, 50(12): 894-901. **Monograph:** *Practical Guide to the Diagnosis and Treatment of Endometriosis* **Other Major Achievements (e.g., Awards):** Runner-up, National Finals, 6th China Obstetrics and Gynecology Network Surgical Video Competition; Runner-up, National Finals, 2018 Aixijie Gynecological Endoscopic Video Competition.
Schedule

Dr. Wang Doctor — Outpatient Schedule

Weekly clinic, including specialist and surgery days. Book 3-7 days in advance.

Clinic: The First Affiliated Hospital, Sun Yat-sen University · Gynecology
On Duty
Off Duty
Period Morning
08:00-12:00
Afternoon
14:00-17:30
Evening
18:30-20:30
Mon Off Duty Off Duty Off Duty
Tue Off Duty Off Duty Off Duty
Wed On Duty
09:00 - 12:00
On Duty
14:00 - 17:00
Off Duty
Thu Off Duty Off Duty Off Duty
Fri Off Duty Off Duty Off Duty
Sat Off Duty Off Duty Off Duty
Sun Off Duty Off Duty Off Duty
Note: Actual clinic hours are subject to the hospital's daily notice. Please call the Dovecure 24h hotline 400-888-0000 to confirm before booking.

Rationale for Precision

Senior Medical Advisory Team — With an average of over five years of clinical experience, the team has supported over 1,000 families in accessing coordinated, high-quality medical care in China.

Book your dedicated advisor now

Senior Medical Advisory Team — With an average of over five years of clinical experience, the team has supported over 1,000 families in accessing coordinated, high-quality medical care in China.

24/7 medical consultation +86 18126771334 (iMessage)
Email Consultation cure@dovecure.com
WeChat dovecure_care
Cart
Your cart is empty
Continue shopping
{{ item.sku_code }} - {{ item.variant_label }} {{ item.item_type_label }}
{{ item.price_format }}
{{ item.subtotal_format }}
Total {{ totalAmount }}
Checkout View Cart
Consult